The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
NF-κB and IKK as therapeutic targets in cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Self-citationNF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Self-citationMaeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Huber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421358 · Cited by 1,033
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Self-citationIKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a
Hu, M. C.-T., Lee, D.-F., Xia, W., Golfman, L. S., Ou-Yang, F., Yang, J.-Y., Zou, Y., Bao, S., Hanada, N., Saso, H., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00302-2 · Cited by 868
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
PI 3-kinase, Akt and cell survival
Downward, J. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.01.002 · Cited by 783
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., Libermann, T. A., Treon, S. P., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202445099 · Cited by 741
Role of NF-κB in p53-mediated programmed cell death
Ryan, K. M., Ernst, M. K., Rice, N. R., & Vousden, K. H. (2000) · Nature · doi:10.1038/35009130 · Cited by 740
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1588 · Cited by 724
Jung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0329fje · Cited by 679
Guzman, M. L., Rossi, R. M., Karnischky, L., Li, X., Peterson, D. R., Howard, D. S., & Jordan, C. T. (2005) · Blood · doi:10.1182/blood-2004-10-4135 · Cited by 678
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Richardson, P. G., Hideshima, T., Munshi, N. C., Treon, S. P., & Anderson, K. C. (2002) · Blood · doi:10.1182/blood.v99.12.4525 · Cited by 669
Transcriptional Cross Talk between NF-κB and p53
Webster, G. A., & Perkins, N. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3485 · Cited by 598
Houston, M. A., Abendroth, K., Baldwin, A. S., & Liu, R. (2001) · PubMed · doi:10.17615/k359-fr77 · Cited by 547
Self-citationNF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., et al. (2003) · Nature · doi:10.1038/nature01283 · Cited by 535
At the Crossroads of Inflammation and Cancer
Clevers, H. (2004) · Cell · doi:10.1016/j.cell.2004.09.005 · Cited by 493
Inhibition of NF-κB Activity by Thalidomide through Suppression of IκB Kinase Activity
Keifer, J. A., Guttridge, D. C., Ashburner, B. P., & Jr.Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100938200 · Cited by 478
Shishodia, S., Amin, H. M., Lai, R., & Aggarwal, B. B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.043 · Cited by 459
Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines
Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P., & Aggarwal, B. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204997 · Cited by 441
Anto, R. J. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.143 · Cited by 429
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin Jr., A. S. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 392
Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB
Campbell, K. J., Rocha, S., & Perkins, N. D. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00131-5 · Cited by 386
β-catenin interacts with and inhibits NF-κB in human colon and breast cancer
Deng, J., Miller, S. A., Wang, H.-Y., Xia, W., Wen, Y., Zhou, B. P., Li, Y., Lin, S.-Y., & Hung, M.-C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00154-x · Cited by 372
Huang, S., Robinson, J. B., DeGuzman, A., Bucana, C. D., & Fidler, I. J. (2000) · PubMed · Cited by 369
Biswas, D. K., Cruz, A. P., Gansberger, E., & Pardee, A. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8542 · Cited by 351
p53 stabilization is decreased upon NFκB activation
Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., & Verma, I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00068-5 · Cited by 313
Lam, L. T., Davis, R. E., Pierce, J., Hepperle, M. E., Xu, Y., Foley, M. H., Nong, Y., Wen, D., Adams, J., Dang, L., et al. (2005) · PubMed · Cited by 312
Takada, Y., Bhardwaj, A., Potdar, P., & Aggarwal, B. B. (2004) · Oncogene · doi:10.1038/sj.onc.1208169 · Cited by 310
Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes
Kim, J. H., Kim, B., Cai, L., Choi, H. J., Ohgi, K. A., Tran, C., Chen, C., Chung, C. H., Huber, O., Rose, D. W., et al. (2005) · Nature · doi:10.1038/nature03452 · Cited by 291
Grandage, V. L., Gale, R. E., Linch, D. C., & Khwaja, A. (2005) · Leukemia · doi:10.1038/sj.leu.2403653 · Cited by 281
Pianetti, S., Arsura, M., Romieu-Mourez, R., Coffey, R. J., & Sonenshein, G. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204257 · Cited by 265
Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells
Kordes, U., Krappmann, D., Heissmeyer, V, Ludwig, W., & Scheidereit, C. (2000) · Leukemia · doi:10.1038/sj.leu.2401705 · Cited by 264
Hinz, M., Löser, P., Mathas, S., Krappmann, D., Dörken, B., & Scheidereit, C. (2001) · Blood · doi:10.1182/blood.v97.9.2798 · Cited by 261
Dhawan, P., Singh, A. B., Ellis, D. L., & Richmond, A. J. (2002) · PubMed · Cited by 260
Müerköster, S., Wegehenkel, K., Arlt, A., Witt, M., Sipos, B., Kruse, M.-L., Sebens, T., Klöppel, G., Kalthoff, H., Fölsch, U. R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1860 · Cited by 254
Yin, D., Zhou, H., Kumagai, T., Liu, G., Ong, J. M., Black, K. L., & Koeffler, H. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208225 · Cited by 232
Fernández, Y., Verhaegen, M., Miller, T. P., Rush, J. L., Steiner, P., Opipari, A. W., Lowe, S. W., & Soengas, M. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0686 · Cited by 222
Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases
Lam, J. S., Yamashiro, J., Shintaku, I. P., Vessella, R. L., Jenkins, R. B., Horvath, S., Said, J. W., & Reiter, R. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1842 · Cited by 211
Landowski, T. H., Megli, C. J., Nullmeyer, K. D., Lynch, R. M., & Dorr, R. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3684 · Cited by 202
Gustin, J. A., Ozes, O. N., Akca, H., Pincheira, R., Mayo, L. D., Li, Q., Guzman, J. R., Korgaonkar, C. K., & Donner, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306976200 · Cited by 199
Shishodia, S., Koul, D., & Aggarwal, B. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.2011 · Cited by 185
Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis
Mathas, S., Lietz, A., Janz, M., Hinz, M., Jundt, F., Scheidereit, C., Bommert, K., & Dörken, B. (2003) · Blood · doi:10.1182/blood-2002-04-1154 · Cited by 174
NF- B constitutes a potential therapeutic target in high-risk myelodysplastic syndrome
Braun, T., Carvalho, G., Coquelle, A., Vozenin, M.-C., Lepelley, P., Hirsch, F., Kiladjian, J.-J., Ribrag, V., Fenaux, P., & Kroemer, G. (2005) · Blood · doi:10.1182/blood-2005-05-1989 · Cited by 166
IKKα Regulates Mitogenic Signaling through Transcriptional Induction of Cyclin D1 via Tcf
Albanese, C., Wu, K., D’Amico, M., Jarrett, C. R., Joyce, D. A., Hughes, J. R., Hulit, J., Sakamaki, T., Fu, M., Ben‐Ze'ev, A., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-06-0101 · Cited by 165
Regulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K., & Perkins, N. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600608 · Cited by 162
Nakshatri, H., Rice, S. E., & Bhat‐Nakshatri, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207995 · Cited by 159
Robe, P. A. J. T., Bentires‐Alj, M., Bonif, M., Rogister, B., Deprez, M., Haddada, H., Khac, M.-T. N., Jolois, O., Erkmen, K., Merville, M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0392 · Cited by 157
Zhou, H., Du, M., & Dixit, V. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.012 · Cited by 145
Frelin, C. (2004) · Blood · doi:10.1182/blood-2004-04-1463 · Cited by 142
Jeang, K. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00028-9 · Cited by 139
NF-κB RelA opposes epidermal proliferation driven by TNFR1 and JNK
Zhang, J. Y., Green, C. L., Tao, S., & Khavari, P. A. (2004) · Genes & Development · doi:10.1101/gad.1160904 · Cited by 135
Nucleolar Sequestration of RelA (p65) Regulates NF-κB-Driven Transcription and Apoptosis
Stark, L. A., & Dunlop, M. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5985-6004.2005 · Cited by 127
Ashikawa, K., Shishodia, S., Fokt, I., Priebe, W., & Aggarwal, B. B. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.039 · Cited by 97
Small, G. W., Shi, Y., Edmund, N. A., Somasundaram, S., Moore, D. T., & Orlowski, R. Z. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.003400 · Cited by 97
Ho, W. C., Dickson, K. M., & Barker, P. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3494 · Cited by 95
Susceptibility of Cholangiocarcinoma Cells to Parthenolide-Induced Apoptosis
Kim, J., Liu, L., Lee, S. O., Kim, Y., You, K.-R., & Kim, D. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4193 · Cited by 92
García, M. G., Alaniz, L. D., Lopes, E. C., Blanco, G. A. C., Hajos, S. E., & Álvarez, É. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.05.004 · Cited by 91
Increased IκB kinase activity is associated with activated NF-κB in acute myeloid blasts
Baumgartner, B., Weber, M., Quirling, M., Fischer, C., Page, S., Adam, M., von Schilling, C., Waterhouse, C., Schmid, C., Neumeier, D., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402641 · Cited by 88
Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro
Subhashini, J., Mahipal, S. V. K., & Reddanna, P. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.11.002 · Cited by 87
Nasr, R., El-Sabban, M. E., Karam, J.-A., Dbaibo, G. S., Kfoury, Y. S., Arnulf, B., Lepelletier, Y., Bex, F., de Thé, H., Hermine, O., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208212 · Cited by 84
Apoptosis Induction by a Novel Retinoid-Related Molecule Requires Nuclear Factor-κB Activation
Farhana, L., Dawson, M. I., & Fontana, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4124 · Cited by 70
Proteasome inhibition in hematologic malignancies
Richardson, P. G. G., Hideshima, T., Mitsiades, C. S., & Anderson, K. C. (2004) · Annals of Medicine · doi:10.1080/07853890410030877 · Cited by 66
Ostrander, J. H., Hawke, N. A., Kashatus, D. F., & Baldwin, A. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3898 · Cited by 52
Self-citationMEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-κB activation
Nawata, R., Yujiri, T., Nakamura, Y., Ariyoshi, K., Takahashi, T., Satō, Y., Oka, Y., & Tanizawa, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206901 · Cited by 45
Rajkumar, S. V. (2003) · Seminars in Hematology · doi:10.1053/j.seminhematol.2003.09.007 · Cited by 15
Cited by
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Zhang, Q., Lenardo, M. J., & Baltimore, D. (2017) · Cell · doi:10.1016/j.cell.2016.12.012 · Cited by 1,982
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
The emerging roles of forkhead box (Fox) proteins in cancer
Myatt, S. S., & Lam, E. W. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2223 · Cited by 1,070
Metadata
- Authors
- Kim, H. J., Hawke, N., & Baldwin, A. S.
- Venue
- Cell Death & Differentiation
- Published
- 2006-02-17
- Volume
- 13
- Issue
- 5
- Pages
- 738-747
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W1986856096
- Cited by
- 391
- References
- 77
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.